The FDA has released a warning to medical professionals about serious complications with transvaginal surgical mesh repair of pelvic organ prolapse (POP). Although patients have been complaining by the hundreds about their surgical mesh complications, the FDA had previously reported these problems as “rare”. That stance has changed as the FDA has now received thousands of reports of “adverse events” associated with surgical mesh procedures.
The FDA has told the medical world in a recent statement that “It is not clear that transvaginal POP repair with mesh is more effective than traditional non-mesh repair in all patients with POP and it may expose patients to greater risk.”
The agency says they will continue to evaluate the effects of using surgical mesh, and will notify the healthcare community of their findings. In the meantime, you can read what other patients have to say here in the comments of our post from 2008.